APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ambulatory Phlebectomy

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Ambulatory Phlebectomy Market Outlook and Growth Opportunities 2026

11 April 2026Not stated

Choose your research edition.

Industry ResearchAmbulatory Phlebectomy Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Ambulatory Phlebectomy Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Ambulatory Phlebectomy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ambulatory Phlebectomy Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Ambulatory Phlebectomy Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

The global Ambulatory Phlebectomy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Ambulatory Phlebectomy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ambulatory Phlebectomy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ambulatory Phlebectomy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Ambulatory Phlebectomy market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Ambulatory Phlebectomy market include Medtronic, Boston Scientific, BD, AngioDynamics, Teleflex, Biolitec AG, B. Braun, Merit Medical and Dornier MedTech, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Ambulatory Phlebectomy market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ambulatory Phlebectomy and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ambulatory Phlebectomy revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Ambulatory Phlebectomy market.

Ambulatory Phlebectomy Segment by Company

Medtronic

Boston Scientific

BD

AngioDynamics

Teleflex

Biolitec AG

B. Braun

Merit Medical

Dornier MedTech

Alma Lasers

Ambulatory Phlebectomy Segment by Type

Traditional Ambulatory Phlebectomy

Transilluminated Powered Phlebectomy (TIPP)

Combined Procedure

Ambulatory Phlebectomy Segment by Application

Hospital

Specialized Vein Clinics

Aesthetic Clinics

Ambulatory Phlebectomy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Ambulatory Phlebectomy status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Ambulatory Phlebectomy key companies, revenue, market share, and recent developments.

3. To split the Ambulatory Phlebectomy breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Ambulatory Phlebectomy market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Ambulatory Phlebectomy significant trends, drivers, influence factors in global and regions.

6. To analyze Ambulatory Phlebectomy competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ambulatory Phlebectomy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ambulatory Phlebectomy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ambulatory Phlebectomy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ambulatory Phlebectomy industry.

Chapter 3: Detailed analysis of Ambulatory Phlebectomy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Ambulatory Phlebectomy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Ambulatory Phlebectomy in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Ambulatory Phlebectomy Industry Trends Table 2. Ambulatory Phlebectomy Industry Drivers Table 3. Ambulatory Phlebectomy Industry Opportunities and Challenges Table 4. Ambulatory Phlebectomy Industry Restraints Table 5. Global Ambulatory Phlebectomy Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Ambulatory Phlebectomy Revenue Share by Company (2021-2026) Table 7. Global Ambulatory Phlebectomy Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Ambulatory Phlebectomy Key Company Manufacturing Base & Headquarters Table 9. Global Ambulatory Phlebectomy Company, Product Type & Application Table 10. Global Ambulatory Phlebectomy Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Ambulatory Phlebectomy by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Traditional Ambulatory Phlebectomy Table 15. Significant Companies of Transilluminated Powered Phlebectomy (TIPP) Table 16. Significant Companies of Combined Procedure Table 17. Global Ambulatory Phlebectomy Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Ambulatory Phlebectomy Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Ambulatory Phlebectomy Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Ambulatory Phlebectomy Sales Value Share by Type (2021-2026) Table 21. Global Ambulatory Phlebectomy Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Hospital Table 23. Significant Companies of Specialized Vein Clinics Table 24. Significant Companies of Aesthetic Clinics Table 25. Global Ambulatory Phlebectomy Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Ambulatory Phlebectomy Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Ambulatory Phlebectomy Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Ambulatory Phlebectomy Sales Value Share by Application (2021-2026) Table 29. Global Ambulatory Phlebectomy Sales Value Share by Application (2027-2032) Table 30. Global Ambulatory Phlebectomy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Ambulatory Phlebectomy Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Ambulatory Phlebectomy Sales Value Share by Region (2021-2026) Table 33. Global Ambulatory Phlebectomy Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Ambulatory Phlebectomy Sales Value Share by Region (2027-2032) Table 35. Global Ambulatory Phlebectomy Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Ambulatory Phlebectomy Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Ambulatory Phlebectomy Sales Value Market Share by Country (2021-2026) Table 38. Global Ambulatory Phlebectomy Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Ambulatory Phlebectomy Sales Value Market Share by Country (2027-2032) Table 40. Medtronic Company Information Table 41. Medtronic Business Overview Table 42. Medtronic Ambulatory Phlebectomy Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Medtronic Ambulatory Phlebectomy Product Portfolio Table 44. Medtronic Recent Development Table 45. Boston Scientific Company Information Table 46. Boston Scientific Business Overview Table 47. Boston Scientific Ambulatory Phlebectomy Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Boston Scientific Ambulatory Phlebectomy Product Portfolio Table 49. Boston Scientific Recent Development Table 50. BD Company Information Table 51. BD Business Overview Table 52. BD Ambulatory Phlebectomy Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. BD Ambulatory Phlebectomy Product Portfolio Table 54. BD Recent Development Table 55. AngioDynamics Company Information Table 56. AngioDynamics Business Overview Table 57. AngioDynamics Ambulatory Phlebectomy Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. AngioDynamics Ambulatory Phlebectomy Product Portfolio Table 59. AngioDynamics Recent Development Table 60. Teleflex Company Information Table 61. Teleflex Business Overview Table 62. Teleflex Ambulatory Phlebectomy Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Teleflex Ambulatory Phlebectomy Product Portfolio Table 64. Teleflex Recent Development Table 65. Biolitec AG Company Information Table 66. Biolitec AG Business Overview Table 67. Biolitec AG Ambulatory Phlebectomy Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Biolitec AG Ambulatory Phlebectomy Product Portfolio Table 69. Biolitec AG Recent Development Table 70. B. Braun Company Information Table 71. B. Braun Business Overview Table 72. B. Braun Ambulatory Phlebectomy Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. B. Braun Ambulatory Phlebectomy Product Portfolio Table 74. B. Braun Recent Development Table 75. Merit Medical Company Information Table 76. Merit Medical Business Overview Table 77. Merit Medical Ambulatory Phlebectomy Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Merit Medical Ambulatory Phlebectomy Product Portfolio Table 79. Merit Medical Recent Development Table 80. Dornier MedTech Company Information Table 81. Dornier MedTech Business Overview Table 82. Dornier MedTech Ambulatory Phlebectomy Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Dornier MedTech Ambulatory Phlebectomy Product Portfolio Table 84. Dornier MedTech Recent Development Table 85. Alma Lasers Company Information Table 86. Alma Lasers Business Overview Table 87. Alma Lasers Ambulatory Phlebectomy Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Alma Lasers Ambulatory Phlebectomy Product Portfolio Table 89. Alma Lasers Recent Development Table 90. Research Programs/Design for This Report Table 91. Authors List of This Report Table 92. Secondary Sources Table 93. Primary Sources List of Figures Figure 1. Ambulatory Phlebectomy Product Image Figure 2. Global Ambulatory Phlebectomy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ambulatory Phlebectomy Market Size (2021-2032) & (US$ Million) Figure 4. Global Ambulatory Phlebectomy Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Traditional Ambulatory Phlebectomy Image Figure 8. Transilluminated Powered Phlebectomy (TIPP) Image Figure 9. Combined Procedure Image Figure 10. Global Ambulatory Phlebectomy Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Ambulatory Phlebectomy Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Ambulatory Phlebectomy Sales Value Share by Type (2021-2032) Figure 13. Hospital Image Figure 14. Specialized Vein Clinics Image Figure 15. Aesthetic Clinics Image Figure 16. Global Ambulatory Phlebectomy Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Ambulatory Phlebectomy Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Ambulatory Phlebectomy Sales Value Share by Application (2021-2032) Figure 19. Global Ambulatory Phlebectomy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Ambulatory Phlebectomy Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Ambulatory Phlebectomy Sales Value (2021-2032) & (US$ Million) Figure 22. North America Ambulatory Phlebectomy Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Ambulatory Phlebectomy Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Ambulatory Phlebectomy Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Ambulatory Phlebectomy Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Ambulatory Phlebectomy Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Ambulatory Phlebectomy Sales Value (2021-2032) & (US$ Million) Figure 28. South America Ambulatory Phlebectomy Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Ambulatory Phlebectomy Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Ambulatory Phlebectomy Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Traditional Ambulatory Phlebectomy
  • Transilluminated Powered Phlebectomy (TIPP)
  • Combined Procedure
Applications
  • Hospital
  • Specialized Vein Clinics
  • Aesthetic Clinics
Companies covered
  • Medtronic
  • Boston Scientific
  • BD
  • AngioDynamics
  • Teleflex
  • Biolitec AG
  • B. Braun
  • Merit Medical
  • Dornier MedTech
  • Alma Lasers

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Ambulatory Phlebectomy Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Ambulatory Phlebectomy Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Ambulatory Phlebectomy Market Dynamics
  1. 2.1 Ambulatory Phlebectomy Industry Trends
  2. 2.2 Ambulatory Phlebectomy Industry Drivers
  3. 2.3 Ambulatory Phlebectomy Industry Opportunities and Challenges
  4. 2.4 Ambulatory Phlebectomy Industry Restraints
3 Ambulatory Phlebectomy Market by Company
  1. 3.1 Global Ambulatory Phlebectomy Company Revenue Ranking in 2025
  2. 3.2 Global Ambulatory Phlebectomy Revenue by Company (2021-2026)
  3. 3.3 Global Ambulatory Phlebectomy Company Ranking (2024-2026)
  4. 3.4 Global Ambulatory Phlebectomy Company Manufacturing Base and Headquarters
  5. 3.5 Global Ambulatory Phlebectomy Company Product Type and Application
  6. 3.6 Global Ambulatory Phlebectomy Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Ambulatory Phlebectomy Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Ambulatory Phlebectomy Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Ambulatory Phlebectomy Market by Type
  1. 4.1 Ambulatory Phlebectomy Type Introduction
  2. 4.1.1 Traditional Ambulatory Phlebectomy
  3. 4.1.2 Transilluminated Powered Phlebectomy (TIPP)
  4. 4.1.3 Combined Procedure
  5. 4.2 Global Ambulatory Phlebectomy Sales Value by Type
  6. 4.2.1 Global Ambulatory Phlebectomy Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Ambulatory Phlebectomy Sales Value by Type (2021-2032)
  8. 4.2.3 Global Ambulatory Phlebectomy Sales Value Share by Type (2021-2032)
5 Ambulatory Phlebectomy Market by Application
  1. 5.1 Ambulatory Phlebectomy Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Specialized Vein Clinics
  4. 5.1.3 Aesthetic Clinics
  5. 5.2 Global Ambulatory Phlebectomy Sales Value by Application
  6. 5.2.1 Global Ambulatory Phlebectomy Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ambulatory Phlebectomy Sales Value by Application (2021-2032)
  8. 5.2.3 Global Ambulatory Phlebectomy Sales Value Share by Application (2021-2032)
6 Ambulatory Phlebectomy Regional Value Analysis
  1. 6.1 Global Ambulatory Phlebectomy Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ambulatory Phlebectomy Sales Value by Region (2021-2032)
  3. 6.2.1 Global Ambulatory Phlebectomy Sales Value by Region: 2021-2026
  4. 6.2.2 Global Ambulatory Phlebectomy Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Ambulatory Phlebectomy Sales Value (2021-2032)
  7. 6.3.2 North America Ambulatory Phlebectomy Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Ambulatory Phlebectomy Sales Value (2021-2032)
  10. 6.4.2 Europe Ambulatory Phlebectomy Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Ambulatory Phlebectomy Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Ambulatory Phlebectomy Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Ambulatory Phlebectomy Sales Value (2021-2032)
  16. 6.6.2 South America Ambulatory Phlebectomy Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Ambulatory Phlebectomy Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Ambulatory Phlebectomy Sales Value Share by Country, 2025 VS 2032
7 Ambulatory Phlebectomy Country-level Value Analysis
  1. 7.1 Global Ambulatory Phlebectomy Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Ambulatory Phlebectomy Sales Value by Country (2021-2032)
  3. 7.2.1 Global Ambulatory Phlebectomy Sales Value by Country (2021-2026)
  4. 7.2.2 Global Ambulatory Phlebectomy Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Ambulatory Phlebectomy Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Ambulatory Phlebectomy Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Ambulatory Phlebectomy Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Medtronic
  2. 8.1.1 Medtronic Company Information
  3. 8.1.2 Medtronic Business Overview
  4. 8.1.3 Medtronic Ambulatory Phlebectomy Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Medtronic Ambulatory Phlebectomy Product Portfolio
  6. 8.1.5 Medtronic Recent Developments
  7. 8.2 Boston Scientific
  8. 8.2.1 Boston Scientific Company Information
  9. 8.2.2 Boston Scientific Business Overview
  10. 8.2.3 Boston Scientific Ambulatory Phlebectomy Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Boston Scientific Ambulatory Phlebectomy Product Portfolio
  12. 8.2.5 Boston Scientific Recent Developments
  13. 8.3 BD
  14. 8.3.1 BD Company Information
  15. 8.3.2 BD Business Overview
  16. 8.3.3 BD Ambulatory Phlebectomy Revenue and Gross Margin (2021-2026)
  17. 8.3.4 BD Ambulatory Phlebectomy Product Portfolio
  18. 8.3.5 BD Recent Developments
  19. 8.4 AngioDynamics
  20. 8.4.1 AngioDynamics Company Information
  21. 8.4.2 AngioDynamics Business Overview
  22. 8.4.3 AngioDynamics Ambulatory Phlebectomy Revenue and Gross Margin (2021-2026)
  23. 8.4.4 AngioDynamics Ambulatory Phlebectomy Product Portfolio
  24. 8.4.5 AngioDynamics Recent Developments
  25. 8.5 Teleflex
  26. 8.5.1 Teleflex Company Information
  27. 8.5.2 Teleflex Business Overview
  28. 8.5.3 Teleflex Ambulatory Phlebectomy Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Teleflex Ambulatory Phlebectomy Product Portfolio
  30. 8.5.5 Teleflex Recent Developments
  31. 8.6 Biolitec AG
  32. 8.6.1 Biolitec AG Company Information
  33. 8.6.2 Biolitec AG Business Overview
  34. 8.6.3 Biolitec AG Ambulatory Phlebectomy Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Biolitec AG Ambulatory Phlebectomy Product Portfolio
  36. 8.6.5 Biolitec AG Recent Developments
  37. 8.7 B. Braun
  38. 8.7.1 B. Braun Company Information
  39. 8.7.2 B. Braun Business Overview
  40. 8.7.3 B. Braun Ambulatory Phlebectomy Revenue and Gross Margin (2021-2026)
  41. 8.7.4 B. Braun Ambulatory Phlebectomy Product Portfolio
  42. 8.7.5 B. Braun Recent Developments
  43. 8.8 Merit Medical
  44. 8.8.1 Merit Medical Company Information
  45. 8.8.2 Merit Medical Business Overview
  46. 8.8.3 Merit Medical Ambulatory Phlebectomy Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Merit Medical Ambulatory Phlebectomy Product Portfolio
  48. 8.8.5 Merit Medical Recent Developments
  49. 8.9 Dornier MedTech
  50. 8.9.1 Dornier MedTech Company Information
  51. 8.9.2 Dornier MedTech Business Overview
  52. 8.9.3 Dornier MedTech Ambulatory Phlebectomy Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Dornier MedTech Ambulatory Phlebectomy Product Portfolio
  54. 8.9.5 Dornier MedTech Recent Developments
  55. 8.10 Alma Lasers
  56. 8.10.1 Alma Lasers Company Information
  57. 8.10.2 Alma Lasers Business Overview
  58. 8.10.3 Alma Lasers Ambulatory Phlebectomy Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Alma Lasers Ambulatory Phlebectomy Product Portfolio
  60. 8.10.5 Alma Lasers Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst